T/CRHA 134-2025
Active
Group standards
T/CRHA 134-2025 The standard for intravenous infusion management of anti-tumor drugs
T/CRHA 134-2025 The standard for intravenous infusion management of anti-tumor drugs
Price:
$ 20.00
Basic Information
Standard Code:
T/CRHA 134-2025
Standard Type:
Group standards
Standard Status:
Active
is_force_gb:
no
CCS Name:
-
ICS Name:
Integrated medical science and healthcare devices
Publish Date:
2025-02-19
Implement Date:
2025-02-28
Scope
Scope: This document specifies the basic requirements, operating procedures, complications and treatments related to intravenous therapy, occupational protection, and waste disposal for the administration of anti-tumor drugs by intravenous infusion; Main technical content: The overall structure adopted in this document is as follows: 1. Scope; 2. Normative reference documents; 3. Terms and definitions; 4. Basic requirements; 5. Operating procedures; 6. Complications and treatments related to intravenous therapy; 7. Occupational protection; 8. Waste disposal. This document is applicable to registered nurses in all levels and types of medical institutions for the management of intravenous infusion of anti-tumor drugs.
Development Information
Related Standards
GB 3232-1982
Abolished
GB 3233-1982
Abolished
GB 3233-1982 Diagnostic criteria and principles of management of occupational chronic carbon disulfide poisoning
GB 3234-1982
Abolished
GB 3234-1982 Diagnostic criteria and principles of management of industrial fluorosis
GB 4865-1985
Abolished
GB 4865-1985 Diagnostic criteria and principles of management of occupational chronic allyl chloride poisoning
GB 4869-1985
Abolished
GB 4869-1985 Diagnostic criteria and principles of management of occupational vibration disease
GB 5044-1985
Abolished